It says it all ...26 Oct 2007 10:03
VALIRX PLC ("ValiRx" or the "Company")
Directorate change and directors' holdings
The Board of ValiRx (AIM: VAL) are pleased to announce that non-executive director, James Nicholas Thorniley, has been appointed non-executive Chairman with immediate effect. His appointment follows the resignation today of Anthony Moore as Chairman who has stood down from the Board to focus on other commercial interests.
Satu Vainikka, CEO of ValiRx, commented:"Anthony has played an instrumental role in the formation of the Company, its funding and admission to AIM. Following the completion of the Company's first year on AIM after the reverse takeover, he felt the timing was right to stand down. The Board would like to thank him for his contribution to the businessover the last two years.
"Further to his resignation, Anthony Moore has informed the Company that he has today disposed of 100,000 ordinary shares of 6p each in the Company ("Ordinary Shares") at 12p per share, reducing his shareholding to 275,000 Ordinary Shares representing 0.87% of the issued ordinary share capital of the Company